Literature DB >> 15920489

Acute megakaryoblastic leukemia in children and adolescents, excluding Down's syndrome: improved outcome with intensified induction treatment.

D Reinhardt, S Diekamp, C Langebrake, J Ritter, J Stary, M Dworzak, A Schrauder, M Zimmermann, G Fleischhack, W-D Ludwig, J Harbott, U Creutzig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15920489     DOI： 10.1038/sj.leu.2403815

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

Review 1.  Prognosis and management of acute myeloid leukemia in patients with Down syndrome.

Authors:  J Timothy Caldwell; Yubin Ge; Jeffrey W Taub
Journal:  Expert Rev Hematol       Date:  2014-09-18       Impact factor: 2.929

Review 2.  The biology of pediatric acute megakaryoblastic leukemia.

Authors:  Tanja A Gruber; James R Downing
Journal:  Blood       Date:  2015-07-17       Impact factor: 22.113

3.  AMKL chimeric transcription factors are potent inducers of leukemia.

Authors:  J Dang; S Nance; J Ma; J Cheng; M P Walsh; P Vogel; J Easton; G Song; M Rusch; A L Gedman; C Koss; J R Downing; T A Gruber
Journal:  Leukemia       Date:  2017-02-08       Impact factor: 11.528

4.  Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study.

Authors:  Hiroto Inaba; Yinmei Zhou; Oussama Abla; Souichi Adachi; Anne Auvrignon; H Berna Beverloo; Eveline de Bont; Tai-Tsung Chang; Ursula Creutzig; Michael Dworzak; Sarah Elitzur; Alcira Fynn; Erik Forestier; Henrik Hasle; Der-Cherng Liang; Vincent Lee; Franco Locatelli; Riccardo Masetti; Barbara De Moerloose; Dirk Reinhardt; Laura Rodriguez; Nadine Van Roy; Shuhong Shen; Takashi Taga; Daisuke Tomizawa; Allen E J Yeoh; Martin Zimmermann; Susana C Raimondi
Journal:  Blood       Date:  2015-07-27       Impact factor: 22.113

5.  Prognostic features in acute megakaryoblastic leukemia in children without Down syndrome: a report from the AML02 multicenter trial and the Children's Oncology Group Study POG 9421.

Authors:  M M O'Brien; X Cao; S Pounds; G V Dahl; S C Raimondi; N J Lacayo; J Taub; M Chang; H J Weinstein; Y Ravindranath; H Inaba; D Campana; C H Pui; J E Rubnitz
Journal:  Leukemia       Date:  2012-08-03       Impact factor: 11.528

6.  RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia.

Authors:  Holly Edwards; Chengzhi Xie; Katherine M LaFiura; Alan A Dombkowski; Steven A Buck; Julie L Boerner; Jeffrey W Taub; Larry H Matherly; Yubin Ge
Journal:  Blood       Date:  2009-07-28       Impact factor: 22.113

7.  Imaging findings of upper abdominal involvement by acute megakaryoblastic leukaemia.

Authors:  Shiori Amemiya; Masaaki Akahane; Junko Takita; Takashi Igarashi; Kuni Ohtomo
Journal:  Pediatr Radiol       Date:  2008-01-03

Review 8.  Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia.

Authors:  C Michel Zwaan; Edward A Kolb; Dirk Reinhardt; Jonas Abrahamsson; Souichi Adachi; Richard Aplenc; Eveline S J M De Bont; Barbara De Moerloose; Michael Dworzak; Brenda E S Gibson; Henrik Hasle; Guy Leverger; Franco Locatelli; Christine Ragu; Raul C Ribeiro; Carmelo Rizzari; Jeffrey E Rubnitz; Owen P Smith; Lillian Sung; Daisuke Tomizawa; Marry M van den Heuvel-Eibrink; Ursula Creutzig; Gertjan J L Kaspers
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

Review 9.  Childhood acute myeloid leukemia.

Authors:  Jeffrey E Rubnitz
Journal:  Curr Treat Options Oncol       Date:  2008-05-28

Review 10.  How I treat pediatric acute myeloid leukemia.

Authors:  Jeffrey E Rubnitz
Journal:  Blood       Date:  2012-05-07       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.